Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.

Small ubiquitin-like modifier (SUMO) modification has emerged as an important posttranslational control of protein functions. Daxx, a transcriptional corepressor, was reported to repress the transcriptional potential of several transcription factors and target to PML oncogenic domains (PODs) via SUMO-dependent interactions. The mechanism by which Daxx binds to sumoylated factors mediating transcriptional and subnuclear compartmental regulation remains unclear. Here, we define a SUMO-interacting motif (SIM) within Daxx and show it to be crucial for targeting Daxx to PODs and for transrepression of several sumoylated transcription factors, including glucocorticoid receptor (GR). In addition, the capability of Daxx SIM to bind SUMO also controls Daxx sumoylation. We further demonstrate that arsenic trioxide-induced sumoylation of PML correlates with a change of endogenous Daxx partitioning from GR-regulated gene promoter to PODs and a relief of Daxx repression on GR target gene expression. Our results provide mechanistic insights into Daxx in SUMO-dependent transcriptional control and subnuclear compartmentalization.

[1]  E. Kieff,et al.  NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Sharrocks,et al.  SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.

[3]  R. Hay,et al.  SUMO: a history of modification. , 2005, Molecular cell.

[4]  David Owerbach,et al.  A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. , 2005, Biochemical and biophysical research communications.

[5]  G. Jenster,et al.  Negative Modulation of Androgen Receptor Transcriptional Activity by Daxx , 2004, Molecular and Cellular Biology.

[6]  Donghai Lin,et al.  Identification of a Substrate Recognition Site on Ubc9* , 2002, The Journal of Biological Chemistry.

[7]  J. Iñiguez-Lluhí,et al.  A Small Conserved Surface in SUMO Is the Critical Structural Determinant of Its Transcriptional Inhibitory Properties , 2005, Molecular and Cellular Biology.

[8]  M. Kaghad,et al.  Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. , 2000, The Journal of biological chemistry.

[9]  Christopher D. Lima,et al.  Structural Basis for E2-Mediated SUMO Conjugation Revealed by a Complex between Ubiquitin-Conjugating Enzyme Ubc9 and RanGAP1 , 2002, Cell.

[10]  Paul Freemont,et al.  Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation , 2001, The Journal of experimental medicine.

[11]  K. Nakayama,et al.  Noncovalent SUMO-1 Binding Activity of Thymine DNA Glycosylase (TDG) Is Required for Its SUMO-1 Modification and Colocalization with the Promyelocytic Leukemia Protein* , 2005, Journal of Biological Chemistry.

[12]  G. Gill,et al.  Something about SUMO inhibits transcription. , 2005, Current opinion in genetics & development.

[13]  S. Weger,et al.  The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation. , 2003, Experimental cell research.

[14]  J. Iñiguez-Lluhí,et al.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Ailan Guo,et al.  The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.

[16]  Ziming Zhang,et al.  Small Ubiquitin-like Modifier (SUMO) Recognition of a SUMO Binding Motif , 2005, Journal of Biological Chemistry.

[17]  G. Gill,et al.  Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. , 2003, Current opinion in genetics & development.

[18]  Erica S. Johnson,et al.  Protein modification by SUMO. , 2004, Annual review of biochemistry.

[19]  P. Freemont,et al.  PML protein isoforms and the RBCC/TRIM motif , 2001, Oncogene.

[20]  T. A. Wilkinson,et al.  Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. de Thé,et al.  Characterization of endogenous human promyelocytic leukemia isoforms. , 2006, Cancer research.

[22]  H. Shih,et al.  Essential Role of the 58-kDa Microspherule Protein in the Modulation of Daxx-dependent Transcriptional Repression as Revealed by Nucleolar Sequestration* , 2002, The Journal of Biological Chemistry.

[23]  J. Iñiguez-Lluhí,et al.  A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.

[24]  K. Yamamoto,et al.  Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Chae,et al.  Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9. , 2000, Biochemical and biophysical research communications.

[26]  Fumio Hanaoka,et al.  Crystal structure of thymine DNA glycosylase conjugated to SUMO-1 , 2005, Nature.

[27]  O. Jänne,et al.  Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. , 2002, The Biochemical journal.

[28]  H. Shih,et al.  SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Jinke Cheng,et al.  Role of desumoylation in the development of prostate cancer. , 2006, Neoplasia.

[30]  A. Dejean,et al.  Conjugation with the ubiquitin‐related modifier SUMO‐1 regulates the partitioning of PML within the nucleus , 1998, The EMBO journal.

[31]  David Reverter,et al.  Insights into E3 ligase activity revealed by a SUMO–RanGAP1–Ubc9–Nup358 complex , 2005, Nature.

[32]  S. Kogan,et al.  A sumoylation site in PML/RARA is essential for leukemic transformation. , 2005, Cancer cell.

[33]  Jennifer O'Neil,et al.  Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML , 2000, Molecular and Cellular Biology.

[34]  G. Maul,et al.  Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX , 2004, Journal of Cell Science.

[35]  Ming-Zong Lai,et al.  Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential* , 2003, The Journal of Biological Chemistry.

[36]  P. Pandolfi,et al.  Regulation of Pax3 transcriptional activity by SUMO-1-modified PML , 2001, Oncogene.

[37]  H. Shih,et al.  Daxx Mediates the Small Ubiquitin-like Modifier-dependent Transcriptional Repression of Smad4* , 2005, Journal of Biological Chemistry.

[38]  E. Yeh,et al.  Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 , 1999, The Journal of cell biology.

[39]  P. Pandolfi,et al.  Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.

[40]  N. Perkins,et al.  P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.

[41]  Min Wang,et al.  The Small Ubiquitin-like Modifier-1 (SUMO-1) Consensus Sequence Mediates Ubc9 Binding and Is Essential for SUMO-1 Modification* , 2001, The Journal of Biological Chemistry.

[42]  F. Melchior,et al.  SUMO: ligases, isopeptidases and nuclear pores. , 2003, Trends in biochemical sciences.

[43]  G. Hayward,et al.  Evaluation of Interactions of Human Cytomegalovirus Immediate-Early IE2 Regulatory Protein with Small Ubiquitin-Like Modifiers and Their Conjugation Enzyme Ubc9 , 2001, Journal of Virology.

[44]  Eunhee Kim,et al.  Modification of Daxx by small ubiquitin-related modifier-1. , 2002, Biochemical and biophysical research communications.